Inhibitory actions of lead on steroidogenesis in MA-10 mouse leydig tumor cells

Archives of Andrology

Volumn 50, Issue 1, 2004, Pages 5-9

  Huang, B M ^a   Liu, M Y ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Camp; Lead; Leydig cell; Progesterone; StAR protein; Steroidogenic enzymes

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; CHORIONIC GONADOTROPIN; CYCLIC AMP; CYTOCHROME P450; LEAD; LEAD ACETATE; PROGESTERONE; STEROIDOGENIC ACUTE REGULATORY PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME ACTIVITY; HORMONE SYNTHESIS; LEYDIG CELL TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL MODEL; STEROIDOGENESIS;

3-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; CELL LINE, TUMOR; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; ENZYME ACTIVATION; HYDROXYCHOLESTEROLS; LEAD; LEYDIG CELL TUMOR; MALE; MICE; PHOSPHOPROTEINS; PROGESTERONE; TESTICULAR NEOPLASMS;

EID: 79961191364     PISSN: 01485016     EISSN: None     Source Type: Journal    
DOI: 10.1080/01485010490250434     Document Type: Article

References (19)

1. Goyer RA (1990): Lead toxicity: from overt to subclinical to subtle health effects. Environ Health Perspect 86:177-181.
2. Hsu PC, Hsu CC, et al. (1998): Lead-induced changes in spermatozoa function and metabolism. J Toxicol Environ Health A 55:45-64.
3. Huang BM, Lai HY, Liu MY (2002): Concentration dependency in lead-inhibited steroidogenesis in MA-10 mouse Leydig tumor cells. J Toxicol Environ Health A 65:557-567.
4. Klein D, Wan YJ, et al. (1994): Effects of toxic levels of lead on gene regulation in the male axis: increase in messenger ribonucleic acids and intracellular stores of gonadotrophs within the central nervous system. Biol Reprod 50:802-811.
5. Lancranjan I, Popescu HI, et al. (1975): Reproductive ability of workmen occupationally exposed to lead. Arch Environ Health 30:396-401.
6. Liu MY, Lai HY, et al. (2001): The inhibitory effects of lead on steroidogenesis in MA-10 mouse Leydig tumor cells. Life Sci 68:849-859.
7. Liu MY, Leu SF, et al. (2003): Inhibitory mechanisms of lead on steroidogenesis in MA-10 mouse Leydig tumor cells. Arch Androl 49:29-38.
8. Lu Y, McDonough A, et al. (1991): Regulation of testicular P-450 cholesterol side-chain cleavage and P-450 C17-20 lyase/C17 hydroxylase enzymes in the neonatal and adult rat. Acta Endocrinol 124:449-454.
9. Ng TB, Liu WK (1990): Toxic effect of heavy metals on cells isolated from the rat adrenal and testis. In Vitro Cell Dev Biol 26:24-28.
10. Nozu K, Dehejia A, et al. (1981): Gonadotropin-induced receptor regulation and steroidogenic lesions in cultured Leydig cells. J Biol Chem 256:12875-12882.
11. Paksy K, Gati I, et al. (2001): Lead accumulation in human ovarian follicular fluid, and in vitro effect of lead on progesterone production by cultured human ovarian granulosa cells. J Toxicol Environ Health A 62:359-366.
12. Pinon-Lataillade G, Thoreux-Manlay A, et al. (1993): Effect of ingestion and inhalation of lead on the reproductive system and fertility of adult male rats and their progeny. Human Exp Toxicol 12:165-172.
13. Sokol RZ (1987): Hormonal effects of lead acetate in the male rat: mechanism of action. Biol Reprod 37:1135-1138.
14. Sokol RZ, Berman N (1991): The effect of age of exposure on lead-induced testicular toxicity. Toxicology 69:269-278.
15. Sokol RZ, Madding CE, Swerdloff RS (1985): Lead toxicity and the hypothalamic-pituitary-testicular axis. Biol Reprod 33:722-728.
16. Sokol RZ, Wang S, et al. (2002): Long-term, low-dose lead exposure alters the gonadotropin-releasing hormone system in the male rat. Environ Health Perspect 110:871-874.
17. Thoreux-Manlay A, Velez de la Calle JF, et al. (1995): Impairment of testicular endocrine function after lead intoxication in the adult rat. Toxicology 100:101-109.
18. Thoreux-Manlay A, Le Goascogne C, et al. (1995): Lead affects steroidogenesis in rat Leydig cells in vivo and in vitro. Toxicology 103:53-62.
19. Wadi SA, Ahmad G (1999): Effects of lead on the male reproductive system in mice. J Toxicol Environ Health A 56:513-521.